Data Monitoring in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Early Termination of the Doxazosin Treatment Arm

Barry R. Davis and Jeffrey A. Cutler
Additional contact information
Barry R. Davis: The University of Texas Health Science Center at Houston, School of Public Health
Jeffrey A. Cutler: National Institutes of Health, National Heart, Lung, and Blood Institute, Division of Epidemiology and Clinical Applications

Chapter Case 18 in Data Monitoring in Clinical Trials, 2006, pp 248-259 from Springer

Abstract: Abstract The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial’s (ALLHAT) hypertension component was designed to determine whether the incidence of fatal coronary heart disease or non-fatal myocardial infarction differs between diuretic (chlorthalidone) treatment and each of three other classes of antihypertensive drugs—a calcium antagonist (amlodipine), an angiotensin-converting enzyme inhibitor (lisinopril), or an alpha-adrenergic blocker (doxazosin) in high-risk hypertensive persons aged 55 years and older. A Data and Safety Monitoring Board met twice yearly to review data on participant recruitment, retention, endpoints, and other patient safety issues. The doxazosin arm of the trial was terminated earlier than planned due to the low likelihood of finding a significant difference in the primary outcome by the study’s scheduled end and a significant 25% increase in cardiovascular events for doxazosin compared with chlorthalidone. This decision was made based on recommendations from an ad hoc review committee following a split vote of the Data and Safety Monitoring Board. This paper describes the monitoring guidelines established for ALLHAT and how they were used, the role of secondary endpoints in DSMB deliberations, advance preparations for possible closeout of a study arm, the role of a Special Review Committee, processes for closeout of the doxazosin arm, and lessons learned.

Keywords: Conditional Power; Prevent Heart Attack Trial; Heart Failure Diagnosis; Heart Failure Case; Cumulative Event Rate (search for similar items in EconPapers)
Date: 2006
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-0-387-30107-5_23

Ordering information: This item can be ordered from
http://www.springer.com/9780387301075

DOI: 10.1007/0-387-30107-0_23

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().